Baricitinib and sotrovimab invited for COVID-19
M
Baricitinib 2mg tablets and sotrovimab solution for infusion, 500 mg/8 mL (62.5 mg/mL) single use vial, invited for COVID-19.
Joint CIPAC/FAO/WHO Meeting on update information
VCP
For information on the Joint CIPAC/FAO/WHO Meeting on update information, click here.
Lupin’s moxifloxacin prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Joint UNICEF-UNFPA-WHO Meeting for Manufacturers and Suppliers - 08-10 March 2022
ID
IVD
IS
M
V
VCP
The World Health Organization (WHO), together with the United Nation’s Children Fund (UNICEF) and the United Nations Population Fund (UNFPA), will hold a three-day virtual meeting on 8-10 March 202